Opioid Advocacy Update From the beginning of the opioid epidemic, the California Medical Association (CMA) has been one of the most engaged and determined stakeholders working to strike a balance between patient access to necessary medicine and preventing and addressing abuse. September 28, 2018 California Legislation, Health Care Reform, Legislation, Resources cma, controlled substances, CURES, opiod, opiod advocacy, opiod crisis, opiod enforcement, opiod epidemic, prescribing opiods, prescription drugs 0 0 Comment Read More »
Are You Ready to Check CURES? Effective October 2, 2018, physicians must consult California’s prescription drug monitoring database (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. All individuals practicing in California who possess both a state regulatory board license authorized to prescribe, dispense, furnish or order controlled substances and a Drug Enforcement Administration Controlled Substance Registration Certificate must be registered to use CURES. June 19, 2018 California Legislation, Legislation, RCMA/CMA controlled substances, CURES, opiods, prescription drugs 0 0 Comment Read More »
2015 Legislative Wrap Up It is difficult to imagine, but the 2015 legislative year was even more challenging than the 2014 legislative year, which included the diversion of staff resources to defeat Proposition 46. With a third of legislators (40 out of 120) serving freshman terms, the California Medical Association’s (CMA) Government Relations staff spent a considerable amount of time during the first quarter educating new legislators and their staff about the mission and policies of CMA. Through our educational efforts, we successfully stopped the introduction of a number of harmful legislative proposals and shifted focus to the passage of CMA’s sponsored bill package. December 1, 2015 California Legislation, Legislation Vaccines, CURES, Physician Aid-in-Dying, Scope of Practice, Workers' Comp 0 0 Comment Read More »
